125 related articles for article (PubMed ID: 33388806)
1. Useful preoperative examination findings to classify the grade of ovarian primary mucinous tumor.
Ohya A; Ichinohe F; Matoba H; Kobara H; Fujinaga Y
Abdom Radiol (NY); 2021 Jun; 46(6):2393-2402. PubMed ID: 33388806
[TBL] [Abstract][Full Text] [Related]
2. Serum CA19-9, CA-125 and CEA as tumor markers for mucinous ovarian tumors.
Lertkhachonsuk AA; Buranawongtrakoon S; Lekskul N; Rermluk N; Wee-Stekly WW; Charakorn C
J Obstet Gynaecol Res; 2020 Nov; 46(11):2287-2291. PubMed ID: 32830422
[TBL] [Abstract][Full Text] [Related]
3. [The value of MRI plain scan and DWI in the diagnosis of brain metastases].
Zhong YH; Yang Q; Liu Z; Wang YF; Li L; Wen J; Liu LJ; Luo DH
Zhonghua Zhong Liu Za Zhi; 2021 Apr; 43(4):466-471. PubMed ID: 33902209
[No Abstract] [Full Text] [Related]
4. [Borderline Ovarian Tumours: CNGOF Guidelines for Clinical Practice - Value of Tumor Markers].
Nyangoh-Timoh K; Bendifallah S; Dion L; Ouldamer L; Levêque J
Gynecol Obstet Fertil Senol; 2020 Mar; 48(3):277-286. PubMed ID: 32004789
[TBL] [Abstract][Full Text] [Related]
5. Longitudinal changes in magnetic resonance imaging of malignant and borderline tumors associated with ovarian endometriotic cyst comparing with endometriotic cysts without arising malignancy.
Nishio N; Kido A; Kataoka M; Kuwahara R; Nakao K; Kurata Y; Matsumura N; Mandai M; Togashi K
Eur J Radiol; 2018 Aug; 105():175-181. PubMed ID: 30017276
[TBL] [Abstract][Full Text] [Related]
6. Role of CA125/CEA ratio and ultrasound parameters in identifying metastases to the ovaries in patients with multilocular and multilocular-solid ovarian masses.
Moro F; Pasciuto T; Djokovic D; Di Legge A; Granato V; Moruzzi MC; Mancari R; Zannoni GF; Fischerova D; Franchi D; Scambia G; Testa AC
Ultrasound Obstet Gynecol; 2019 Jan; 53(1):116-123. PubMed ID: 29978587
[TBL] [Abstract][Full Text] [Related]
7. MRI appearances of mucinous borderline ovarian tumors: pathological correlation.
Ma FH; Zhao SH; Qiang JW; Zhang GF; Wang XZ; Wang L
J Magn Reson Imaging; 2014 Sep; 40(3):745-51. PubMed ID: 24395397
[TBL] [Abstract][Full Text] [Related]
8. MRI appearance of ovarian serous borderline tumors of the micropapillary type compared to that of typical ovarian serous borderline tumors: radiologic-pathologic correlation.
Nakai G; Yamada T; Yamamoto K; Hirose Y; Ohmichi M; Narumi Y
J Ovarian Res; 2018 Jan; 11(1):7. PubMed ID: 29321056
[TBL] [Abstract][Full Text] [Related]
9. Combination of cyst fluid CEA and CA 125 is an accurate diagnostic tool for differentiating mucinous cystic neoplasms from intraductal papillary mucinous neoplasms.
Nagashio Y; Hijioka S; Mizuno N; Hara K; Imaoka H; Bhatia V; Niwa Y; Tajika M; Tanaka T; Ishihara M; Shimizu Y; Hosoda W; Yatabe Y; Yamao K
Pancreatology; 2014; 14(6):503-9. PubMed ID: 25458668
[TBL] [Abstract][Full Text] [Related]
10. Malignant or borderline mucinous cystic neoplasms have a larger number of loculi than mucinous cystadenoma: a retrospective study with MR.
Okamoto Y; Tanaka YO; Tsunoda H; Yoshikawa H; Minami M
J Magn Reson Imaging; 2007 Jul; 26(1):94-9. PubMed ID: 17659568
[TBL] [Abstract][Full Text] [Related]
11. Factors associated with misdiagnosis of frozen section of mucinous borderline ovarian tumor.
Zhang W; Jia S; Xiang Y; Yang J; Jia C; Leng J
J Int Med Res; 2019 Jan; 47(1):96-104. PubMed ID: 30198356
[TBL] [Abstract][Full Text] [Related]
12. Differentiation between borderline and benign ovarian tumors: combined analysis of MRI with tumor markers for large cystic masses (≥5 cm).
Park SY; Oh YT; Jung DC
Acta Radiol; 2016 May; 57(5):633-9. PubMed ID: 26231948
[TBL] [Abstract][Full Text] [Related]
13. Analysis of MRI Values and Hemoglobin and Total Protein Concentrations of Cystic Ovarian Tumors.
Tanaka Y; Nakai G; Yamamura K; Yamamoto K; Narumi Y; Ohmichi M
J Magn Reson Imaging; 2019 Apr; 49(4):1133-1140. PubMed ID: 30240525
[TBL] [Abstract][Full Text] [Related]
14. Assessment of combination of contrast-enhanced magnetic resonance imaging and positron emission tomography/computed tomography for evaluation of ovarian masses.
Tsuboyama T; Tatsumi M; Onishi H; Nakamoto A; Kim T; Hori M; Sakane M; Hori Y; Morii E; Hatazawa J; Tomiyama N
Invest Radiol; 2014 Aug; 49(8):524-31. PubMed ID: 24637584
[TBL] [Abstract][Full Text] [Related]
15. Can MRI features differentiate ovarian mucinous carcinoma from mucinous borderline tumor?
Kaga T; Kato H; Hatano Y; Kawaguchi M; Furui T; Morishige KI; Matsuo M
Eur J Radiol; 2020 Nov; 132():109281. PubMed ID: 32961452
[TBL] [Abstract][Full Text] [Related]
16. CEA in evaluation of adnexal mass: retrospective cohort analysis and review of the literature.
Sagi-Dain L; Lavie O; Auslander R; Sagi S
Int J Biol Markers; 2015 Nov; 30(4):e394-400. PubMed ID: 26109367
[TBL] [Abstract][Full Text] [Related]
17. Value of diffusion-weighted imaging combined with conventional magnetic resonance imaging in the diagnosis of thecomas/fibrothecomas and their differential diagnosis with malignant pelvic solid tumors.
Yin B; Li W; Cui Y; Chu C; Ding M; Chen J; Zhang P; Wu X
World J Surg Oncol; 2016 Jan; 14(1):5. PubMed ID: 26744173
[TBL] [Abstract][Full Text] [Related]
18. Comparison of prognostic value of different MRI classifications of signal intensity change in cervical spondylotic myelopathy.
Avadhani A; Rajasekaran S; Shetty AP
Spine J; 2010 Jun; 10(6):475-85. PubMed ID: 20494809
[TBL] [Abstract][Full Text] [Related]
19. Is there a correlation between tumor marker panel and tumor size and histopathology in well staged patients with borderline ovarian tumors?
Ayhan A; Guven S; Guven ES; Kucukali T
Acta Obstet Gynecol Scand; 2007; 86(4):484-90. PubMed ID: 17486473
[TBL] [Abstract][Full Text] [Related]
20. Serum CA 125, carcinoembryonic antigen, and CA 19-9 as tumor markers in borderline ovarian tumors.
Engelen MJ; de Bruijn HW; Hollema H; ten Hoor KA; Willemse PH; Aalders JG; van der Zee AG
Gynecol Oncol; 2000 Jul; 78(1):16-20. PubMed ID: 10873403
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
